LabCorp Buy of Genzyme Genetics Clears FTC | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said that its $925 million proposed acquisition of Genzyme Genetics has cleared antitrust review.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.